✦ LIBER ✦

Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG

✍ Scribed by M. Joerger; A. D. R. Huitema; D. J. Richel; C. Dittrich; N. Pavlidis; E. Briasoulis; J. B. Vermorken; E. Strocchi; A. Martoni; R. Sorio; H. P. Sleeboom; M. A. Izquierdo; D. I. Jodrell; A. H. Calvert; A. Boddy; H. Hollema; R. Féty; W. J. F. Van der Vijgh; G. Hempel; E. Chatelut; M. Karlsson; B. Tranchand; A. H. G. J. Schrijvers; J. H. Beijnen; J. H. M. Schellens

Book ID: 108641828
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 127 KB
Volume: 63
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2007.02886_4.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

496 A phase II study of alternating pacl

496 A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer

✍ M. Adams; D. Mort; R. Coleman; L. Williams; A. Evans; M. Thompson 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Phase II study of sequential doublets: t

Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer

✍ Alan N Gordon; Lina Asmar; Mark J Messing; Daron G Street; Charles H Pippitt Jr. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Sequential gemcitabine–carboplatin follo

Sequential gemcitabine–carboplatin followed by paclitaxel–carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study

✍ Johanna U. Mäenpää; Seija E. Grénman; Jyrki T. Jalkanen; Tapio A. Kuoppala; Arto 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

A phase II study of sequential carboplat

A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer

✍ Guppy, A E; Nelstrop, A E; Foster, T; Agarwal, R; Seckl, M J; Rustin, G J S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Phase 1A/B study of combination carbopla

Phase 1A/B study of combination carboplatin, paclitaxel and ridaforolim- us in patients with solid, endometrial, and ovarian cancers

✍ Chon, H.; Herschberger, A.; Lee, J.; Wenham, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

A phase I study evaluating the safety an

A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer

✍ A.L. LEISER; F.C. MALUF; D.S. CHI; P. SABBATINI; M.L. HENSLEY; L. SCHWARTZ; E. V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB